Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

Yoshimasa Saito, Gangning Liang, Gerda Egger, Jeffrey M. Friedman, Jody C. Chuang, Gerhard A. Coetzee, Peter A. Jones

Research output: Contribution to journalArticle

1070 Citations (Scopus)

Abstract

Expression profiling of T24 cells revealed that 17 out of 313 human miRNAs were upregulated more than 3-fold by simultaneous treatment with the chromatin-modifying drugs 5-aza-2′-deoxycytidine and 4-phenylbutyric acid. One of these, miR-127, is embedded in a CpG island and is highly induced from its own promoter after treatment. miR-127 is usually expressed as part of a miRNA cluster in normal cells but not in cancer cells, suggesting that it is subject to epigenetic silencing. In addition, the proto-oncogene BCL6, a potential target of miR-127, was translationally downregulated after treatment. These results suggest that DNA demethylation and histone deacetylase inhibition can activate expression of miRNAs that may act as tumor suppressors.

Original languageEnglish
Pages (from-to)435-443
Number of pages9
JournalCancer Cell
Volume9
Issue number6
DOIs
Publication statusPublished - 2006 Jun 13
Externally publishedYes

Fingerprint

Proto-Oncogenes
MicroRNAs
Chromatin
Down-Regulation
decitabine
Pharmaceutical Preparations
Neoplasms
CpG Islands
Histone Deacetylases
Epigenomics
DNA

Keywords

  • CELLCYCLE
  • DNA
  • RNA

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. / Saito, Yoshimasa; Liang, Gangning; Egger, Gerda; Friedman, Jeffrey M.; Chuang, Jody C.; Coetzee, Gerhard A.; Jones, Peter A.

In: Cancer Cell, Vol. 9, No. 6, 13.06.2006, p. 435-443.

Research output: Contribution to journalArticle

Saito, Yoshimasa ; Liang, Gangning ; Egger, Gerda ; Friedman, Jeffrey M. ; Chuang, Jody C. ; Coetzee, Gerhard A. ; Jones, Peter A. / Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. In: Cancer Cell. 2006 ; Vol. 9, No. 6. pp. 435-443.
@article{2519f5f776bc43c4866eb8db32f8e968,
title = "Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells",
abstract = "Expression profiling of T24 cells revealed that 17 out of 313 human miRNAs were upregulated more than 3-fold by simultaneous treatment with the chromatin-modifying drugs 5-aza-2′-deoxycytidine and 4-phenylbutyric acid. One of these, miR-127, is embedded in a CpG island and is highly induced from its own promoter after treatment. miR-127 is usually expressed as part of a miRNA cluster in normal cells but not in cancer cells, suggesting that it is subject to epigenetic silencing. In addition, the proto-oncogene BCL6, a potential target of miR-127, was translationally downregulated after treatment. These results suggest that DNA demethylation and histone deacetylase inhibition can activate expression of miRNAs that may act as tumor suppressors.",
keywords = "CELLCYCLE, DNA, RNA",
author = "Yoshimasa Saito and Gangning Liang and Gerda Egger and Friedman, {Jeffrey M.} and Chuang, {Jody C.} and Coetzee, {Gerhard A.} and Jones, {Peter A.}",
year = "2006",
month = "6",
day = "13",
doi = "10.1016/j.ccr.2006.04.020",
language = "English",
volume = "9",
pages = "435--443",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

AU - Saito, Yoshimasa

AU - Liang, Gangning

AU - Egger, Gerda

AU - Friedman, Jeffrey M.

AU - Chuang, Jody C.

AU - Coetzee, Gerhard A.

AU - Jones, Peter A.

PY - 2006/6/13

Y1 - 2006/6/13

N2 - Expression profiling of T24 cells revealed that 17 out of 313 human miRNAs were upregulated more than 3-fold by simultaneous treatment with the chromatin-modifying drugs 5-aza-2′-deoxycytidine and 4-phenylbutyric acid. One of these, miR-127, is embedded in a CpG island and is highly induced from its own promoter after treatment. miR-127 is usually expressed as part of a miRNA cluster in normal cells but not in cancer cells, suggesting that it is subject to epigenetic silencing. In addition, the proto-oncogene BCL6, a potential target of miR-127, was translationally downregulated after treatment. These results suggest that DNA demethylation and histone deacetylase inhibition can activate expression of miRNAs that may act as tumor suppressors.

AB - Expression profiling of T24 cells revealed that 17 out of 313 human miRNAs were upregulated more than 3-fold by simultaneous treatment with the chromatin-modifying drugs 5-aza-2′-deoxycytidine and 4-phenylbutyric acid. One of these, miR-127, is embedded in a CpG island and is highly induced from its own promoter after treatment. miR-127 is usually expressed as part of a miRNA cluster in normal cells but not in cancer cells, suggesting that it is subject to epigenetic silencing. In addition, the proto-oncogene BCL6, a potential target of miR-127, was translationally downregulated after treatment. These results suggest that DNA demethylation and histone deacetylase inhibition can activate expression of miRNAs that may act as tumor suppressors.

KW - CELLCYCLE

KW - DNA

KW - RNA

UR - http://www.scopus.com/inward/record.url?scp=33744805399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744805399&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2006.04.020

DO - 10.1016/j.ccr.2006.04.020

M3 - Article

C2 - 16766263

AN - SCOPUS:33744805399

VL - 9

SP - 435

EP - 443

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 6

ER -